Literature DB >> 9513888

Feline chronic renal failure: clinical findings in 80 cases diagnosed between 1992 and 1995.

J Elliott1, P J Barber.   

Abstract

Clinical and laboratory findings at the time of first diagnosis in 80 cats with chronic renal failure (CRF) were examined in a prospective study to determine the survival time of these animals and identify possible factors contributing to the progression of feline CRF. On the basis of clinical presentation, animals were assigned to one of three groups; compensated (n = 15), uraemic (n = 39) and end-stage (n = 26) CRF. Loss of renal concentrating ability was a common finding, even before clinical signs of renal disease were evident. The plasma creatinine concentration at initial presentation was a poor predictor of survival time and the presence of significant anaemia was indicative of a poor prognosis. The study demonstrated the highly variable degree of renal impairment present at the time of diagnosis and the potentially long survival time of many compensated and uraemic cases.

Entities:  

Mesh:

Year:  1998        PMID: 9513888     DOI: 10.1111/j.1748-5827.1998.tb03598.x

Source DB:  PubMed          Journal:  J Small Anim Pract        ISSN: 0022-4510            Impact factor:   1.522


  26 in total

1.  Prevalence and classification of chronic kidney disease in cats randomly selected from four age groups and in cats recruited for degenerative joint disease studies.

Authors:  Christina L Marino; B Duncan X Lascelles; Shelly L Vaden; Margaret E Gruen; Steven L Marks
Journal:  J Feline Med Surg       Date:  2013-11-11       Impact factor: 2.015

Review 2.  Novel treatment strategies for chronic kidney disease: insights from the animal kingdom.

Authors:  Peter Stenvinkel; Johanna Painer; Makoto Kuro-O; Miguel Lanaspa; Walter Arnold; Thomas Ruf; Paul G Shiels; Richard J Johnson
Journal:  Nat Rev Nephrol       Date:  2018-01-15       Impact factor: 28.314

3.  A lentiviral gene therapy strategy for the in vitro production of feline erythropoietin.

Authors:  Natalia Vapniarsky; Michael Lame; Samantha McDonnel; Brian Murphy
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

4.  Pathology in Captive Wild Felids at German Zoological Gardens.

Authors:  Johannes Junginger; Florian Hansmann; Vanessa Herder; Annika Lehmbecker; Martin Peters; Martin Beyerbach; Peter Wohlsein; Wolfgang Baumgärtner
Journal:  PLoS One       Date:  2015-06-18       Impact factor: 3.240

5.  Comparison of Efficacy of Long-term Oral Treatment with Telmisartan and Benazepril in Cats with Chronic Kidney Disease.

Authors:  U Sent; R Gössl; J Elliott; H M Syme; T Zimmering
Journal:  J Vet Intern Med       Date:  2015-10-16       Impact factor: 3.333

6.  A retrospective study of 1,098 blood samples with anemia from adult cats: frequency, classification, and association with serum creatinine concentration.

Authors:  E Furman; E Leidinger; E H Hooijberg; N Bauer; G Beddies; A Moritz
Journal:  J Vet Intern Med       Date:  2014 Sep-Oct       Impact factor: 3.333

7.  Comparative palatability of five supplements designed for cats suffering from chronic renal disease.

Authors:  Natalia Bernachon; Sandrine Fournel; Hugues Gatto; Patricia Monginoux; David McGahie
Journal:  Ir Vet J       Date:  2014-05-19       Impact factor: 2.146

8.  Plasma renin activity and aldosterone concentrations in hypertensive cats with and without azotemia and in response to treatment with amlodipine besylate.

Authors:  R E Jepson; H M Syme; J Elliott
Journal:  J Vet Intern Med       Date:  2013-11-13       Impact factor: 3.333

9.  The Effect of Chinese rhubarb, Rheum officinale, with and without benazepril on the progression of naturally occurring chronic kidney disease in cats.

Authors:  A S Hanzlicek; C J Roof; M W Sanderson; G F Grauer
Journal:  J Vet Intern Med       Date:  2014-04-28       Impact factor: 3.333

10.  Relationship between Plasma Fibroblast Growth Factor-23 Concentration and Survival Time in Cats with Chronic Kidney Disease.

Authors:  R F Geddes; J Elliott; H M Syme
Journal:  J Vet Intern Med       Date:  2015-09-25       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.